Horizon Technology Finance Corp
HTFC
New York Stock Exchange24.81
USD
-0.11
- -
CIK
0001487428
ISIN
US44045A5083
CUSIP
44045A508
Return %
Stock
S&P500
1Y
-0.36
19.01
3Y
3.20
65.48
5Y
0.77
72.20
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Michael Balkin
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 312 Farmington Avenue Farmington DE United States of America
- IPO Date
- Jun 28, 2022
- CIK
- 0001487428
- Website
- horizontechfinance.com
- Similar Companies
- Business
- Horizon Technology Finance Corporation (NASDAQ: HRZN) operates as a business development company that provides secured debt and venture lending to venture capital-backed development-stage companies in the technology, life science, healthcare information and services, cleantech, and sustainability industries; its core products include first-lien and second-lien loans, revenue-based financing, equity co-investments via warrants, and customized debt facilities supporting research and development, product commercialization, and working capital needs; the firm generates current income from interest on these debt investments and capital appreciation from warrants, while offering portfolio management services such as financial monitoring, covenant compliance, and risk mitigation. Horizon Technology Finance targets U.S.-based enterprises with proven technology, strong management teams, and clear growth paths, typically partnering with established venture investors to structure financings that complement equity rounds; it serves growth-stage and late-stage companies across these sectors, with a focus on minimizing dilution through flexible, collateralized loan solutions at competitive rates. Founded in 2008 and headquartered at 312 Farmington Avenue, Farmington, Connecticut, the company functions as an affiliate of Monroe Capital and is externally managed by Horizon Technology Finance Management LLC; key executives include CEO Michael Balkin, President Gerald A. Michaud, and Chief Investment Officer Paul George Seitz. Recent developments encompass origination of over $100 million in new loans during Q1 2025, including $25.5 million to Castle Creek Biosciences for gene therapies and $59.1 million across select investments by Q4 2024; portfolio expansions via acquisition of a co-lender's $2.9 million debt position at a discount and strengthening of committed backlog to $235.5 million; balance sheet enhancements through a $40 million convertible notes offering and at-the-market equity program capital raises in Q3 2025; and progression toward a merger with Monroe Capital Corporation (MRCC), announced in Q2 2025 and anticipated to close in Q4 2025 as a tax-free reorganization adding approximately $165 million in equity capital to create a larger platform for venture lending opportunities with operational synergies and cost savings.
Horizon Technology Finance (HRZN) Q1 2026 Earnings Call Transcript